Literature DB >> 24555583

Imaging characteristics of pathologically proven thymic hyperplasia: identifying features that can differentiate true from lymphoid hyperplasia.

Tetsuro Araki1, Lynette M Sholl, Victor H Gerbaudo, Hiroto Hatabu, Mizuki Nishino.   

Abstract

OBJECTIVE: The purpose of this article is to investigate the imaging characteristics of pathologically proven thymic hyperplasia and to identify features that can differentiate true hyperplasia from lymphoid hyperplasia.
MATERIALS AND METHODS: Thirty-one patients (nine men and 22 women; age range, 20-68 years) with pathologically confirmed thymic hyperplasia (18 true and 13 lymphoid) who underwent preoperative CT (n=27), PET/CT (n=5), or MRI (n=6) were studied. The length and thickness of each thymic lobe and the transverse and anterior-posterior diameters and attenuation of the thymus were measured on CT. Thymic morphologic features and heterogeneity on CT and chemical shift on MRI were evaluated. Maximum standardized uptake values were measured on PET. Imaging features between true and lymphoid hyperplasia were compared.
RESULTS: No significant differences were observed between true and lymphoid hyperplasia in terms of thymic length, thickness, diameters, morphologic features, and other qualitative features (p>0.16). The length, thickness, and diameters of thymic hyperplasia were significantly larger than the mean values of normal glands in the corresponding age group (p<0.001). CT attenuation of lymphoid hyperplasia was significantly higher than that of true hyperplasia among 15 patients with contrast-enhanced CT (median, 47.9 vs 31.4 HU; Wilcoxon p=0.03). The receiver operating characteristic analysis yielded greater than 41.2 HU as the optimal threshold for differentiating lymphoid hyperplasia from true hyperplasia, with 83% sensitivity and 89% specificity. A decrease of signal intensity on opposed-phase images was present in all four cases with in- and opposed-phase imaging. The mean maximum standardized uptake value was 2.66.
CONCLUSION: CT attenuation of the thymus was significantly higher in lymphoid hyperplasia than in true hyperplasia, with an optimal threshold of greater than 41.2 HU in this cohort of patients with pathologically confirmed thymic hyperplasia.

Entities:  

Mesh:

Year:  2014        PMID: 24555583      PMCID: PMC4020512          DOI: 10.2214/AJR.13.11210

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  29 in total

Review 1.  Imaging of the thymus.

Authors:  D S Mendelson
Journal:  Chest Surg Clin N Am       Date:  2001-05

2.  Thymic enlargement and FDG uptake in three patients: CT and FDG positron emission tomography correlated with pathology.

Authors:  Conrad Wittram; Allan J Fischman; Eugene Mark; Jane Ko; Jo-Anne O Shepard
Journal:  AJR Am J Roentgenol       Date:  2003-02       Impact factor: 3.959

3.  The pathology of the thymus gland in myasthenia gravis.

Authors:  B Castleman
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

4.  Computed tomography of the normal thymus.

Authors:  R L Baron; J K Lee; S S Sagel; R R Peterson
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105

Review 5.  Thymoma.

Authors:  H K Müller-Hermelink; A Marx
Journal:  Curr Opin Oncol       Date:  2000-09       Impact factor: 3.645

6.  FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT.

Authors:  T Nakahara; H Fujii; M Ide; N Nishiumi; W Takahashi; S Yasuda; A Shohtsu; A Kubo
Journal:  Br J Radiol       Date:  2001-09       Impact factor: 3.039

Review 7.  Spectrum of thymic uptake at 18F-FDG PET.

Authors:  Brett Ferdinand; Pramod Gupta; Elissa L Kramer
Journal:  Radiographics       Date:  2004 Nov-Dec       Impact factor: 5.333

8.  Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy.

Authors:  I Brink; M J Reinhardt; S Hoegerle; C Altehoefer; E Moser; E U Nitzsche
Journal:  J Nucl Med       Date:  2001-04       Impact factor: 10.057

9.  Is thymectomy necessary in nonmyasthenic patients with early thymoma?

Authors:  Yen-Chiang Tseng; Chih-Cheng Hsieh; Hsin-Yi Huang; Chien-Sheng Huang; Wen-Hu Hsu; Biing-Shiun Huang; Min-Hsiung Huang; Han-Shui Hsu
Journal:  J Thorac Oncol       Date:  2013-07       Impact factor: 15.609

10.  Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings.

Authors:  T Pirronti; P Rinaldi; A P Batocchi; A Evoli; C Di Schino; P Marano
Journal:  Acta Radiol       Date:  2002-07       Impact factor: 1.701

View more
  13 in total

Review 1.  Thymic hyperplasia in patients with Graves' disease.

Authors:  M Dalla Costa; F A Mangano; C Betterle
Journal:  J Endocrinol Invest       Date:  2014-08-23       Impact factor: 4.256

2.  Cystic thymic degeneration with pseudoepitheliomatous hyperplasia in a Beagle puppy: an idiopathic lesion?

Authors:  Giulia Moretti; Monica Sforna; Domenico Caivano; Luca Mechelli; Antonello Bufalari; Ilaria Porcellato
Journal:  J Vet Diagn Invest       Date:  2020-04-10       Impact factor: 1.279

3.  Normal thymus in adults: appearance on CT and associations with age, sex, BMI and smoking.

Authors:  Tetsuro Araki; Mizuki Nishino; Wei Gao; Josée Dupuis; Gary M Hunninghake; Takamichi Murakami; George R Washko; George T O'Connor; Hiroto Hatabu
Journal:  Eur Radiol       Date:  2015-04-30       Impact factor: 5.315

4.  Diffusion-weighted MRI in a case of nonsuppressing rebound thymic hyperplasia on chemical-shift MRI.

Authors:  Adriano Massimiliano Priola; Dario Gned; Valerio Marci; Andrea Veltri; Sandro Massimo Priola
Journal:  Jpn J Radiol       Date:  2015-01-04       Impact factor: 2.374

5.  Thymic measurements in pathologically proven normal thymus and thymic hyperplasia: intraobserver and interobserver variabilities.

Authors:  Tetsuro Araki; Lynette M Sholl; Victor H Gerbaudo; Hiroto Hatabu; Mizuki Nishino
Journal:  Acad Radiol       Date:  2014-06       Impact factor: 3.173

6.  Patterns of metastasis and recurrence in thymic epithelial tumours: longitudinal imaging review in correlation with histological subtypes.

Authors:  A Khandelwal; L M Sholl; T Araki; N H Ramaiya; H Hatabu; M Nishino
Journal:  Clin Radiol       Date:  2016-06-03       Impact factor: 2.350

7.  Intrathymic cyst: clinical and radiological features in surgically resected cases.

Authors:  T Araki; L M Sholl; V H Gerbaudo; H Hatabu; M Nishino
Journal:  Clin Radiol       Date:  2014-05-10       Impact factor: 2.350

8.  Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome.

Authors:  Mizuki Nishino; Anita Giobbie-Hurder; Nikhil H Ramaiya; F Stephen Hodi
Journal:  J Immunother Cancer       Date:  2014-11-18       Impact factor: 13.751

9.  Anterior Mediastinal Masses in the Framingham Heart Study: Prevalence and CT Image Characteristics.

Authors:  Tetsuro Araki; Mizuki Nishino; Wei Gao; Josée Dupuis; George R Washko; Gary M Hunninghake; Takamichi Murakami; George T O'Connor; Hiroto Hatabu
Journal:  Eur J Radiol Open       Date:  2015

10.  Rebound thymic hyperplasia after adrenalectomy in a patient with Cushing syndrome caused by adrenocortical adenoma: A case report.

Authors:  Jung Won Hwang; Pyoung Han Hwang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.